JC

Justin Cho

Chief Business Officer

Nano Pharmasolutions

Nano Pharmasolutions Pipeline

DrugIndicationPhase
NT-301Neurological Disorder (Likely Parkinson's Disease)Phase 1
NT-401CNS DisorderPreclinical
NT-501CNS DisorderPreclinical